LEXICON PHARMACEUTICALS, INC. — Director's Dealing 2017

Nov 14, 2017

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: LEXICON PHARMACEUTICALS, INC. (LXRX)
CIK: 0001062822
Period of Report: 2017-11-14

Reporting Person: WADE JEFFREY L (EVP, Corp Adm Affairs and CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2017-11-14	Common Stock	P	2000	$9.4809	Acquired	50597	Direct